SummitTX Capital’s Amrize Ltd AMRZ Stock Holding History

SummitTX Capital’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,100	Closed	-$1.12M	–	1017
2025 Q3	$1.12M	Buy	+23,100	New	+$1.18M	0.05%	361

Other funds holding AMRZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

SummitTX Capital's AMRZ Position: Q4 2025 in Review

SummitTX Capital sold out of Amrize Ltd (AMRZ) in Q4 2025, closing a stake of 23,100 shares — an estimated $1.12M sold.

SummitTX Capital first reported a position in AMRZ in Q3 2025 and held it in 1 quarter. The position peaked at $1.12M in Q3 2025. 387 funds tracked by Wall St. Rank hold AMRZ as of Q4 2025.

SummitTX Capital reported no remaining Amrize Ltd position as of Q4 2025 after selling out during the quarter.
SummitTX Capital sold 23,100 Amrize Ltd shares in Q4 2025, an estimated $1.12M.
SummitTX Capital first reported a position in Amrize Ltd in Q3 2025 and held it in 1 quarter.
SummitTX Capital's Amrize Ltd position peaked at $1.12M in Q3 2025.
387 funds tracked by Wall St. Rank held Amrize Ltd as of Q4 2025.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.